TLN2 and nonpapillary renal cell carcinoma: Moreover, we found sensitivity to six drugs (AZD1332, MK‐2206, SB52334, Linsitinib, LDN‐193189, BMS‐754807, and Cediranib) for ccRCC was negatively associated with expression of TLN2.